Navigation Links
Testosterone Lawsuit News: Bernstein Liebhard LLP Notes Recent Study Finding Dramatic Rise in Canadian Men Taking Hormone Therapy Treatments
Date:7/18/2014

New York, NY (PRWEB) July 18, 2014

Concerns surrounding certain testosterone treatments (http://www.injurybeacon.com/testosterone-androgel/) continued to reach new heights this month with a new study that found a significant increase in the number of Canadian men taking the medications over 15 years, Bernstein Liebhard LLP reports.

The study was published July 16th in an online version of the journal PLOS ONE, and revealed a 310 percent increase in Ontario men using testosterone-raising treatments between 1997 and 2012. According to a Huffington Post report that relayed its results, 28,477 men aged 66 and older were included in the research, which also found that only 6 percent of individuals taking the drugs were diagnosed with hypogonadism, a condition associated with abnormally-low levels of the hormone.*A number of testosterone lawsuits filed in the U.S. allege strokes, heart attacks, blood clots and other cardiovascular problems caused by hormone-raising treatments, court documents indicate.

“As our Firm continues to hear from men who allegedly sustained heart attacks, strokes deep vein thrombosis and other serious heart problems after taking AndroGel, Testim and several other medications, we find the results of this study deeply troubling,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential testosterone lawsuit evaluations to men who were allegedly harmed as a result of these hormone-raising therapies.

Testosterone Lawsuits
According to court documents updated on July 15th, a least 156 testosterone lawsuits are now pending in a multidistrict litigation (MDL) currently underway in the U.S. District Court, Northern District of Illinois. Cases filed in this proceeding allege that the makers of AndroGel and other medications failed to adequately warn men and about cardiovascular side effects that may stem from use of their products.

The litigation surrounding low testosterone therapies has continued to grow since January, when the U.S. Food and Drug Administration (FDA) issued a public health alert that vowed to investigate the safety of “Low T” testosterone medications. The warning was issued on January 31, 2014, after two studies revealed an increased risk for heart attacks, strokes and death in younger men with pre-existing heart disease and all older men.

Men who may have been harmed due to their use of drugs like Androgel may be entitled to file their own testosterone treatment lawsuit. To learn more, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*huffingtonpost.ca/2014/07/16/number-of-men-on-replacem_n_5592433.html,
Huffington Post, July 17, 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.injurybeacon.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/testosterone-lawsuit/androgel-lawsuit/prweb12029668.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Number of Testosterone Therapy Lawsuits More than Doubles in Two-Week Period, Baron and Budd Reports
2. FDA Requires Testosterone Medication Manufacturers to Add Expanded Blood Clot Risk to Warning Labels, Baron and Budd Reports
3. Testosterone Treatment Lawsuit: Bernstein Liebhard LLP Notes Health Canada Alert on Possible Association Between Low Testosterone Therapy, Cardiovascular Problems
4. How much testosterone is too much for women after menopause?
5. No credible evidence to support cardiac risk of testosterone therapy
6. Low testosterone levels may indicate worsening of disease for men with prostate cancer
7. The Lancet Diabetes & Endocrinology: Large clinical trials to evaluate risks of testosterone treatment urgently needed
8. Screening instrument to identify testosterone deficiency
9. Male health linked to testosterone exposure in womb, study finds
10. Endocrine Society calls for large-scale studies to evaluate testosterone therapy risks
11. Testosterone isnt the help some hoped for when women go through menopause early
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... 13, 2016 , ... The National Association for Children of ... representing the growing community of recovering individuals (now over 23 million), to issue ... policies addressing addiction. , Although many of the presidential candidates of both ...
(Date:2/13/2016)... ... February 13, 2016 , ... In its newly released ... visualization technology should be used to ensure patient safety when placing an IV ... Standards mandate the use of vein visualization technology in patients with difficult venous ...
(Date:2/13/2016)... ... February 13, 2016 , ... DDi , a Makro ... list for its expertise in eClinical Solutions. DDi has built its solution competency ... needs of global clients. DDi provides smarter technology for Clinical Development, Regulatory and ...
(Date:2/12/2016)... Washington, DC (PRWEB) , ... ... ... the Siemens Foundation today announced a new initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to ... settings. The partnership will recruit top students from U.S. universities who will ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Each year, the ... be held in Anaheim, CA at the Anaheim Convention Center. Almost 10,000 physical therapists ... new therapy products in action, learn more about their chosen field and network with ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... , Feb. 11, 2016 ... Companion Diagnostics in Personalized Medicine and Cancer Therapy. ... - High-Growth Diagnostic Testing Markets. - Key Diagnostic ... - Molecular Diagnostics in Genetic Testing. - ... Diagnostics Markets. - Over-the-Counter Diagnostic Products World Markets. ...
(Date:2/11/2016)... SAN FRANCISCO , Feb. 11, 2016  Kindred ... focused on saving and improving the lives of pets, ... Technical Section of the New Animal Drug Application (NADA) ... the pivotal field study (KB0120) of Zimeta for the ... by the Company. --> ...
(Date:2/11/2016)... BURLINGAME, Calif. , Feb. 11, 2016  NOIT™ ... announced a special "Gift of Change" campaign to assist ... units. For every such unit sold between February 10, ... a unit to a needy family. The NOIT is ... helping non/limited-verbal autistic individuals develop language skills. ...
Breaking Medicine Technology: